What does CATHLAB do?

CATHLAB is an events organiser in Brugge. Private Limited, started on 26 June 2013, 1 establishment.

What is the address of CATHLAB?

The registered office of CATHLAB is located at Ruddershove 10, 8000 Brugge.

Is CATHLAB still active?

Yes. According to the CBE (29 October 2026) CATHLAB is active, legal situation “Normale toestand”, started on 26 June 2013.

Is CATHLAB registered on Peppol?

Yes, CATHLAB is registered on the Peppol network with ID 0208:0536262619.

What is the enterprise number of CATHLAB?

The enterprise number of CATHLAB is BE0536262619.

When was CATHLAB founded?

CATHLAB was founded on 26 June 2013.

Is CATHLAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 June 2013; 4 annual accounts filed, latest fiscal year 2025; 10 directors known from the annual account.

How much profit did CATHLAB make in 2025?

CATHLAB posted a profit after taxes of € 71,478 in financial year 2025.

What is the revenue of CATHLAB?

As a small company, CATHLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 94,328.

CATHLAB (Private Limited) - Brugge - BE0536262619

Q: Who are the directors of CATHLAB?

According to the 2025 annual accounts, the directors of CATHLAB are: Jan VAN DER HEYDEN, Jean-Benoit LE POLAIN DE WAROUX, Maarten DE SMET, Philippe DEBONNAIRE, Ian BUYSSCHAERT, Mattias DUYTSCHAEVER, Sander TRENSON, Rene TAVERNIER.

Dossier CATHLAB, printed on 29 October 2026 from databakkes.be/en/0536262619/cathlab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

37 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

CATHLAB from Brugge, company number BE0536262619, closed financial year 2025 with a result of € 71,478 after tax. For that financial year CATHLAB recorded a gross margin of € 94,328 and equity of € 56,046. Compared with financial year 2024, the result moved from € -15,164 to € 71,478. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 29, 2026.

What it is worth Growing

€ 56,046

▲ € 51,478 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 71,478

▲ still € 15,164 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 77,463

▲ € 72,455 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

28 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 7,072

▼ 57% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 40,300 Gross margin 2022: € 40,300 First fiscal year in the series	€ 26,495 Gross margin 2023: € 26,495 ▼ 34% vs 2022 (€ 40,300) Unfavourable step	€ -14,377 Gross margin 2024: € -14,377 ▼ € 40,871 vs 2023 (€ 26,495) Unfavourable step	€ 94,328 Gross margin 2025: € 94,328 ▲ € 108,705 vs 2024 (€ -14,377) Favourable step	▲ € 108,705
Profit after taxes	€ 32,125 Profit after taxes 2022: € 32,125 First fiscal year in the series	€ 18,078 Profit after taxes 2023: € 18,078 ▼ 44% vs 2022 (€ 32,125) Unfavourable step	€ -15,164 Profit after taxes 2024: € -15,164 ▼ € 33,241 vs 2023 (€ 18,078) Unfavourable step	€ 71,478 Profit after taxes 2025: € 71,478 ▲ € 86,641 vs 2024 (€ -15,164) Favourable step	▲ € 86,641
Equity	€ 19,654 Equity 2022: € 19,654 First fiscal year in the series	€ 19,732 Equity 2023: € 19,732 Unchanged (€ 19,654) Favourable step	€ 4,568 Equity 2024: € 4,568 ▼ 77% vs 2023 (€ 19,732) Unfavourable step	€ 56,046 Equity 2025: € 56,046 ▲ € 51,478 vs 2024 (€ 4,568) Favourable step	▲ € 51,478
Total debts	€ 96,070 Total debts 2022: € 96,070 First fiscal year in the series	€ 21,365 Total debts 2023: € 21,365 ▼ 78% vs 2022 (€ 96,070) Favourable step	€ 25,350 Total debts 2024: € 25,350 ▲ 19% vs 2023 (€ 21,365) Unfavourable step	€ 27,072 Total debts 2025: € 27,072 ▲ 7% vs 2024 (€ 25,350) Unfavourable step	▲ 7%
Cash	€ 103,880 Cash 2022: € 103,880 First fiscal year in the series	€ 37,501 Cash 2023: € 37,501 ▼ 64% vs 2022 (€ 103,880) Unfavourable step	€ 5,008 Cash 2024: € 5,008 ▼ 87% vs 2023 (€ 37,501) Unfavourable step	€ 77,463 Cash 2025: € 77,463 ▲ € 72,455 vs 2024 (€ 5,008) Favourable step	▲ € 72,455
Retained profit	€ 11,683 Retained profit 2022: € 11,683 First fiscal year in the series	€ 11,760 Retained profit 2023: € 11,760 ▲ 1% vs 2022 (€ 11,683) Favourable step	€ -3,403 Retained profit 2024: € -3,403 ▼ € 15,164 vs 2023 (€ 11,760) Unfavourable step	€ 48,074 Retained profit 2025: € 48,074 ▲ € 51,478 vs 2024 (€ -3,403) Favourable step	▲ € 51,478
Dividend	€ 31,500 Dividend 2022: € 31,500 First fiscal year in the series	€ 18,000 Dividend 2023: € 18,000 ▼ 43% vs 2022 (€ 31,500) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 18,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 115,724 Balance sheet total 2022: € 115,724 First fiscal year in the series	€ 41,097 Balance sheet total 2023: € 41,097 ▼ 64% vs 2022 (€ 115,724) Unchanged	€ 29,919 Balance sheet total 2024: € 29,919 ▼ 27% vs 2023 (€ 41,097) Unchanged	€ 83,118 Balance sheet total 2025: € 83,118 ▲ 178% vs 2024 (€ 29,919) Unchanged	▲ 178%

Key figures of CATHLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to CATHLAB?

What happened at CATHLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 29, 2026 New annual accounts for financial year 2025: profit of € 71,478. Source: NBB ↗
2025 Maarten DE SMET became a director. NBB
2021 Ian BUYSSCHAERT became a director. NBB
2021 Sander TRENSON became a director. NBB
2020 Jean-Benoit LE POLAIN DE WAROUX became a director. NBB
2018 Jan VAN DER HEYDEN became a director. NBB
2016 Philippe DEBONNAIRE became a director. NBB
2016 Sébastien KNECHT became a director. NBB

In short

From € 32,125 profit in 2022 to € 71,478 profit in 2025.

Paid € 36,978 in corporate taxes since 2022.

Best year ever: 2025, with € 71,478 profit.

Paid out € 69,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jan VAN DER HEYDEN Jean-Benoit LE POLAIN DE WAROUX Maarten DE SMET Philippe DEBONNAIRE +6

Dr. Van der Heyden Jan

Rayos Medicinal

CATHLAB

CARDIOFT

Behind CATHLAB are Jan VAN DER HEYDEN, Jean-Benoit LE POLAIN DE WAROUX, Maarten DE SMET, Philippe DEBONNAIRE, Ian BUYSSCHAERT and Mattias DUYTSCHAEVER. Jan VAN DER HEYDEN is also behind Dr. Van der Heyden Jan and Rayos Medicinal. Philippe DEBONNAIRE is also behind CARDIOFT.

Directors

According to the 2025 annual accounts

Jan VAN DER HEYDEN

Director

Also active at: Dr. Van der Heyden Jan, Rayos Medicinal

since 2018

Jean-Benoit LE POLAIN DE WAROUX

Director

since 2020

Maarten DE SMET

Director

since 2025

Philippe DEBONNAIRE

Director

Also active at: CARDIOFT

since 2016

Ian BUYSSCHAERT

Director

Also active at: AMPLO, B & G DOCTORS ASSOCIATES

since 2021

Mattias DUYTSCHAEVER

Director

Also active at: CARDIOLOGIE DR. MATTIAS DUYTSCHAEVER

since 2013

Sander TRENSON

Director

Also active at: DR. SANDER TRENSON, PHABELLA

since 2021

Rene TAVERNIER

Director

since 2013

Sébastien KNECHT

Director

since 2016

Patrick COUSSEMENT

Director

Also active at: DOKTER PATRICK COUSSEMENT

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Ruddershove 10

8000 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 37 companies are registered at this address.

All companies at this address →

AZ ST-JAN Brugge

INSTITUUT VOOR MEDISCHE DRINGENDE HULPVERLENING - CENTER FOR URGENT MEDICAL ASSISTANCE

€ 90,876 revenue · 2025

Wetenschappelijk Fonds Hematologie

ONCOLOGISCH CENTRUM AZ SINT - JAN AV

DIENST ALGEMENE VAAT-EN HEELKUNDE

+32 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0536.262.619

VAT number

BE 0536.262.619

Registered office

Ruddershove 10, 8000 Brugge

Names & denominations

CATHLAB

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 June 2013

Peppol

Active · Active since 13 Dec 2025

Activities · NACE

Organisatie van congressen en beurzen

Uitgeven van boeken

View on CBE Public ↗ Annual accounts (NBB) ↗

CATHLAB

Warning lights

Financials

What happened to CATHLAB?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions